{"filings":[{"id":96429,"accession_number":"0001868726-26-000035","cik":1868726,"company_name":"OLAPLEX HOLDINGS, INC.","ticker":"OLPX","form_type":"8-K","filed_at":"2026-05-11T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Olaplex Q1 net sales up 2.5% to $99.4M but swings to net loss of $5.3M; adjusted EBITDA falls 26.1%","event_type":"earnings","confidence":"high","bullets":["Net sales up 2.5% to $99.4M; Specialty Retail -13.3% to $33.4M, Professional +12.3% to $38.8M, DTC +13.8% to $27.2M.","Net loss of $5.3M vs net income of $0.5M; diluted EPS -$0.01 (vs $0.00).","Adjusted EBITDA fell 26.1% to $19.0M; adjusted EBITDA margin 19.1% vs 26.5%.","Adjusted net income down 19.1% to $10.6M; adjusted diluted EPS flat at $0.02."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":99369000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110310,"accession_number":"0001193125-26-126362","cik":1868726,"company_name":"OLAPLEX HOLDINGS, INC.","ticker":"OLPX","form_type":"8-K","filed_at":"2026-03-26T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Olaplex to be acquired by Henkel for $2.06 per share ($1.4B equity value)","event_type":"m_and_a","confidence":"high","bullets":["Cash consideration of $2.06/share represents ~55% premium over 3/25/26 close and ~45% premium over 30-day VWAP.","Advent International, holding ~75% voting power, approved transaction by written consent; no stockholder vote required.","Closing expected in H2 2026, subject to regulatory approvals including HSR, German, Australian, and UK clearances.","Termination fee of $40.44M payable to Henkel under specified circumstances, including failure to deliver stockholder consent.","OLAPLEX will continue as a brand under Henkel; Advent fully exits at close; Nasdaq listing will be terminated."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.95,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110309,"accession_number":"0001868726-26-000006","cik":1868726,"company_name":"OLAPLEX HOLDINGS, INC.","ticker":"OLPX","form_type":"8-K","filed_at":"2026-03-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Olaplex Q4 sales up 4.3% to $105.1M; net loss widens to $13.1M from $8.8M","event_type":"earnings","confidence":"high","bullets":["Q4 net loss of $13.1M ($0.02 diluted EPS loss) vs $8.8M loss ($0.01 loss) a year ago.","Full-year net sales $423.0M (+0.1%); net loss $9.3M vs net income $19.5M in 2024.","Q4 by channel: Specialty Retail -14.5% to $24.7M, Professional +18.9% to $36.8M, DTC +6.6% to $43.6M.","Adjusted EBITDA Q4 $12.9M (12.2% margin) vs $17.5M (17.4%); FY $93.9M (22.2%) vs $129.7M (30.7%).","CEO cites 'Bonds & Beyond' transformation and renewed brand momentum entering 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126908,"accession_number":"0001868726-25-000105","cik":1868726,"company_name":"OLAPLEX HOLDINGS, INC.","ticker":"OLPX","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Olaplex Q3 net sales fall 3.8%, net income down 24.8%; reaffirms guidance","event_type":"earnings","confidence":"high","bullets":["Net sales $114.6M, down 3.8% YoY; US sales -14.6%, international +7.1%.","Net income $11.1M (down 24.8%); diluted EPS flat at $0.02.","Adjusted EBITDA $30.8M (down 31.0%); margin contracted to 26.9% from 37.5%.","SG&A surged 49.2% to $64.1M; adjusted SG&A up 26.8%.","Company reaffirms annual guidance; CEO cites early results from new product launches."],"consensus_eps_estimate":null,"consensus_eps_actual":0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":317841000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143697,"accession_number":"0001193125-25-188088","cik":1868726,"company_name":"OLAPLEX HOLDINGS, INC.","ticker":"OLPX","form_type":"8-K","filed_at":"2025-08-26T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Olaplex acquires biotech firm Purvala Bioscience for $10.5M in cash","event_type":"m_and_a","confidence":"high","bullets":["Purchase price $10.5M, subject to adjustments; $1.05M escrowed for 15 months for indemnification.","Purvala is a Boston biotech founded by MIT professor Dr. Bradley Olsen, focused on bioinspired molecules for health/beauty.","This is Olaplex's first acquisition since its launch over 10 years ago, signaling renewed innovation push.","Olaplex CEO Amanda Baldwin said Purvala tech could create 'next generation of disruptive science-backed product innovation'."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143696,"accession_number":"0001868726-25-000079","cik":1868726,"company_name":"OLAPLEX HOLDINGS, INC.","ticker":"OLPX","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Olaplex Q2 net loss $7.7M vs prior-year income; revenue up 2.3% to $106.3M","event_type":"earnings","confidence":"high","bullets":["Net loss of $7.7M (diluted EPS -$0.01) vs net income of $5.8M ($0.01) in Q2 2024.","Revenue $106.3M (+2.3%); Professional channel +12.1% to $37.4M, DTC +12.8% to $38.5M, Specialty Retail -16.7% to $30.4M.","Adjusted EBITDA $24.6M (-23.4% YoY); adjusted EBITDA margin 23.1% vs 30.8%.","CEO Amanda Baldwin cites multi-pronged transformation and 'Bonds and Beyond' strategy progress."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":203262000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143695,"accession_number":"0001868726-25-000072","cik":1868726,"company_name":"OLAPLEX HOLDINGS, INC.","ticker":"OLPX","form_type":"8-K","filed_at":"2025-07-22T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Olaplex Holdings Elects Jerome Griffith as Class I Director","event_type":"leadership","confidence":"high","bullets":["Jerome Griffith, age 67, elected to the board effective July 20, 2025, with a term expiring at the 2028 annual meeting.","Griffith previously served as CEO of Brown Jordan, Lands' End, and Tumi Holdings, and held leadership roles at Esprit and Tommy Hilfiger.","He will receive an annual cash retainer of $100,000 and an initial RSU grant valued at approximately $150,000 under the company's compensation policy.","Griffith also serves on the boards of Samsonite International, Vince Holding Corp., and Brown Jordan Inc."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161910,"accession_number":"0001868726-25-000066","cik":1868726,"company_name":"OLAPLEX HOLDINGS, INC.","ticker":"OLPX","form_type":"8-K","filed_at":"2025-06-12T23:59:59+00:00","items":["5.02","5.07"],"status":"ready","headline":"Olaplex holds 2025 annual meeting; director Paula Zusi departs, three Class I directors elected","event_type":"leadership","confidence":"high","bullets":["Paula Zusi's term ended after not being nominated for re-election at the June 10 annual meeting.","John P. Bilbrey, Deirdre Findlay, and Michael White elected as Class I directors with over 93% for votes.","Advisory say-on-pay approved: 607.6M for, 6.0M against, 0.7M abstain (98% of votes cast).","Deloitte & Touche ratified as independent auditor for FY2025 with 628.4M for, 1.1M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}